China Growth Stocks

[diggg]

FWIW (BSPM) - China Biotech Week in Review: A Multitude of Deals and Collaborations

http://seekingalpha.com/article/167161-china-biotech-week-in-review-a-multitude-of-deals-and-collaborations?source=yahoo

Biostar Pharmaceuticals (BSPM.OB) received a China patent for Aoxing Ganbao, an external use TCM treatment for hepatitis B (see story). Biostar already has name recognition in the hepatitis B sector with its flagship product, Xin Aoxing Oleanolic Acid Capsules. Xin Aoxing Oleanolic capsules, which is the only OTC oral hepatitis treatment product approved by the SFDA, generates about 50% of Biostar’s revenues.